浙江普洛康裕制药有限公司
Zhejiang Apeloa Kangyu Pharmaceutical Co. Ltd.
Country: CN CDE+DMF+CEP VERY_HIGH
🇨🇳 CDE
30
32 products shown
🇺🇸 DMF
7
7 products shown
🇪🇺 CEP
8
9 products shown
Total
45
registrations
🇨🇳 CDE 注册 (32)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Alfacalcidol 阿法骨化醇 | 41294-56-8 | Class A | Y20190002277 |
| Amantadine 盐酸金刚烷胺 | 768-94-5 | Class A | Y20190007789 |
| Azithromycin 阿奇霉素 | 83905-01-5 | Class A | Y20190002533 |
| Baloxavir Marboxil 玛巴洛沙韦 | 1985606-14-1 | Class I | Y20250001470 |
| Calcium Pantothenate 泛酸钙 | 137-08-6 | Class A | Y20190002569 |
| Cefetamet 盐酸头孢他美酯 | 65052-63-3 | Class A | Y20190002275 |
| Cetirizine 盐酸西替利嗪 | 83881-51-0 | Class I | Y20260000664 |
| Dextromethorphan 氢溴酸右美沙芬 | 125-71-3 | Class A | Y20170000450 |
| Diphenhydramine 盐酸苯海拉明 | 58-73-1 | Class I | Y20260000429 |
| Donafenib Tosylate 甲苯磺酸多纳非尼 | 86266-22-0 | Class A | Y20230000652 |
| Ephedrine 硫酸麻黄碱 | 134-38-5 | Class A | Y20240000630 |
| Ephedrine Hydrochloride 盐酸麻黄碱 | 299-42-3 | Class A | Y20190002278 |
| Indapamide 吲达帕胺 | 26807-65-8 | Class A | Y20190002264 |
| Levofloxacin 左氧氟沙星 | 100986-85-4 | Class A | Y20190009507 |
| Lomerizine 盐酸洛美利嗪 | - | Class A | Y20190007724 |
| Memantine 盐酸美金刚 | - | Class A | Y20190000110 |
| Ofloxacin 氧氟沙星 | 82419-36-1 | Class A | Y20190002494 |
| Ofloxacin 氧氟沙星 | 82419-36-1 | Class A | Y20190002276 |
| Ofloxacin 氧氟沙星 | 82419-36-1 | Class A | Y20190002247 |
| Oseltamivir 磷酸奥司他韦 | 196618-13-0 | Class A | Y20220000876 |
| Palonosetron 盐酸帕洛诺司琼 | 135729-61-2 | Class A | Y20200001277 |
| Parecoxib Sodium 帕瑞昔布钠 | 198470-84-7 | Class A | Y20170000838 |
| Pemafibrate 佩玛贝特 | 848259-27-8 | Class I | Y20250001268 |
| Piroxicam 吡洛西利 | 36322-90-4 | Class I | Y20260000615 |
| Povidone-iodine 聚维酮碘 | 25655-41-8 | Class A | Y20190007820 |
| Prefovirs 甲磺酸普雷福韦 | 117020-41-4 | Class A | Y20230000200 |
| Pretomanid 普托马尼 | 187235-37-6 | Class A | Y20240000063 |
| Pseudoephedrine Hydrochloride 盐酸伪麻黄碱 | 90-82-4 | Class A | Y20190002263 |
| Rimantadine Hydrochloride 盐酸金刚乙胺 | 13392-28-4 | Class A | Y20190002542 |
| Simvastatin 辛伐他汀 | 79902-63-9 | Class A | Y20190002843 |
| Ubenimex 乌苯美司 | 58970-76-6 | Class A | Y20190002274 |
| Upadacitinib 乌帕替尼 | 1310726-60-3 | Class I | Y20260000726 |
🇺🇸 DMF 注册 (7)
| Product | CAS | DMF Number | Date |
|---|---|---|---|
| Amantadine Hydrochloride USP | 665-66-7 | 25151 | 2011-07-21 |
| Dextromethorphan Hydrobromide | 125-69-9 | 34902 | 2020-08-26 |
| Levofloxacin Hemihydrate, USP | 138199-71-0 | 19511 | 2006-06-06 |
| Lovastatin USP, Non-sterile Active Pharmaceutical Ingredient 洛伐他汀 | 75330-75-5 | 19217 | 2006-03-01 |
| Oxo-acid Dipa Salt, Drug Substance Intermediate | - | 20782 | 2007-08-17 |
| Pseudoephedrine Hydrochloride USP 盐酸伪麻黄碱 | 345-78-8 | 18271 | 2005-03-31 |
| Tylosin Tartrate 泰乐菌素 | 74610-55-2 | 25211 | 2011-08-05 |
🇪🇺 CEP 注册 (9)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Dextromethorphan Hydrobromide Monohydrate | 6700-34-1 | CEP 2021-026 - Rev 01 | 2025-01-02 |
| Dextromethorphan Hydrobromide Monohydrate | 6700-34-1 | R0-CEP 2014-094 - Rev 01 | 2016-05-18 |
| Ivermectin 伊维菌素 | 70288-86-7 | R0-CEP 2006-008 - Rev 01 | 2010-06-17 |
| Levofloxacin Hemihydrate 左氧氟沙星（供注射用） | 138199-71-0 | CEP 2020-128 - Rev 01 | 2026-04-24 |
| Marbofloxacin For Veterinary Use | 115550-35-1 | R1-CEP 2016-269 - Rev 00 | 2023-01-26 |
| Ofloxacin 氧氟沙星 | 82419-36-1 | R1-CEP 2002-146 - Rev 02 | 2011-02-07 |
| Ofloxacin, Process H 盐酸安妥沙星 | 82419-36-1 | CEP 2021-213 - Rev 01 | 2023-10-06 |
| Pseudoephedrine Hydrochloride 盐酸伪麻黄碱 | 90-82-4 | R1-CEP 2005-129 - Rev 00 | 2012-06-06 |
| Simvastatin 辛伐他汀 | 79902-63-9 | R0-CEP 2004-283 - Rev 02 | 2009-04-15 |
Source: cde+fda_direct; DMF高置信 | Updated: 2026-09-11 06:00:12